A Combination of Rituximab and Varlilumab Immunotherapy in Patients with B-cell Lymphoma
Clinical trial NCT03307746 · COMPLETED
Trial details
- NCT number
- NCT03307746
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-23
- Primary completion
- 2021-02-18
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.